Sfoglia per Rivista HAEMATOLOGICA
The factor V HR2 haplotype and the risk of venous thrombosis : a meta-analysis.
2003 G. Castaman, E.M. Faioni, A. Tosetto, F. Bernardi
Factor X Shanghai : a mutation disrupting translocation to the endoplasmic reticulum
2005 R. Asselta
Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia
2002 F. Peyvandi, M. Lak, P.M. Mannucci
Factors associated with iron accumulation in non-transfusion-dependent thalassaemia syndromes : baseline data from multicenter international deferasirox study (THALASSA)
2010 A. Taher, V. Viprakasit, J. Porter, A. Kattamis, T. Lawniczeck, R. Pereno, O. Schoenborn Kellenberger, M.D. Cappellini
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies : two case reports
2017 G. Grossi, M. Viganò, F. Facchetti, S. Labanca, A. Loglio, A. Dodero, V. Montefusco, P. Corradini, A. Cafro, R. Cairoli, M. Colombo, P. Lampertico
Ferrochelatase gene : molecular analysis in Italian patients with erythropoietic protoporphyria
2005 E. Di Pierro, V. Moriondo, D. Tavazzi, P. Bonara, L. Perego, M.D. Cappellini
Fetal hemoglobin induction by a new histone deacetylase inhibitor
2011 L. Ronzoni, G. Fossati, M. Baroni, A. Cattaneo, A. Colancecco, M. Forino, D. Modena, M. Moras, M.D. Cappellini
Fibrinogen Mumbai : intracellular retention due to a novel G434D mutation in the Bbeta-chain gene
2006 L. Monaldini, R. Asselta, S. Duga, F. Peyvandi, K. Ghosh, M. Malcovati, M.L. Tenchini
Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
1997 Trotti R, Siragusa S, Rondanelli M, Chezzi L, Citterio A, Melzi d'Eril GV, Piovella F.
Final report 50F GISL LL02 trials for thr treatment of low-grade non- follicular non- Hodgkin lymphoma, at diagnosis
2007 M. Goldaniga, M. Merli, F. Callea, F. Ilariucci, C. Stelitano, M. Russo, P. Mazza, S. Luminari, M. Brugiatelli, D. Luisi, F. Rossi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
First line therapy with lenalidomide and dexamethasone in primary plasma cell leukemia
2010 P. Musto, F. D’Auria, M.T. Petrucci, F. Morabito, F. Nobile, M. Offidani, F. Di Raimondo, N. Cascavilla, T. Cravita, T. Olivieri, N. Filardi, A. Falcone, R. Lerose, E. Zifarone, A. Zonno, V. Callea, A. Levi, C. Mazzone, G. Pietrantuono, M.C. Martorelli, O. Villani, R. Guariglia, G. Mansueto, A. Neri, K. Todoerti, P. Omedè, S. Bringhen, M. Cavo, M. Boccadoro, A. Palumbo
Flow cytometric evaluation of the bone marrow plasma cell populations in patients with multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis
2007 F. Morabito, E. Vigna, C. Mazzone, N. Caruso, K. Todoerti, M. Gentile, M.G. Bisconte, C. Gentile, G. Lambertenghi Deliliers, S. Cavalcanti, A. Neri
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies
1991 S. Siena, M. Bregni, B. Brando, N. Belli, P.M. Lansdorp, G. Bonadonna, M. Gianni
Fludarabine and cyclophosphamide combination in the treatment of patients with indolent non-follicular B-cell non-Hodgkin’s lynphoma. Results of a phase II trial by the Gruppo Italiano per lo Studio dei Linfomi-GISL
2005 S. Luminari, M. Brugiatelli, M. Goldaniga, F. Merli, A. Bagnulo, M. Russo, V. Fregoni, A.M. Sirotti, M. Federico, G. Lambertenghi Deliliers, L. Baldini
Fludarabine, cyclophosphamide and rituximab in patients with advanced untreated indolent B-cell non-follicular lymphomas : final result of phase two study of Fondazione Italiana Linfomi (FIL)
2011 A. Ferrario, A. Pulsoni, B. Olivero, G. Rossi, F. De Angelis, U. Vitolo, A. Tedeschi, F. Merli, L. Rigacci, C. Stelitano, M. Goldaniga, D. Mannina, P. Musto, F. Rossi, E. Runggaldier, E. Gamba, L. Baldini
Fludarabine-Ifosfamide-Rituximab (FIR): a therapeutic option for chronic lymphocytic leukemia patients resistant to Chlorambucil
2006 A. Cortelezzi, M. Pasquini, G. Reda, F. Ripamonti, D. G Lambertenghi
Fluvastatin reduces aortic tissue factor expression in cholesterol-fed rabbits
2000 M. Camera, S. Del Rosso, B. Gabrielli, F. Rossi, E. Tremoli
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma
2010 A. Ferrario, A. Aghemo, M. Goldaniga, F.G. Rossi, E. De Gasperi, A. Fracanzani, B. Olivero, L. Cro, S. Fargion, G. Lambertenghi Deliliers, L. Baldini
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial
2010 A. Ferrario, M. Goldaniga, F. Merli, V. Callea, F. Ilariucci, C. Stelitano, M. Russo, P. Mazza, S. Luminari, L. Marcheselli, M. Brugiatelli, D. Luisi, F. Rossi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
Functional differences between dendritic cells derived from CD34+ bone marrow and peripheral blood stem cells
2000 F. Servida, D. Soligo, G. Lambertenghi Deliliers
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile